GlassScriptPrepare for your visit
Christopher Cenzer
Family Medicine · Fenton, MI · NPI 1093383895
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$1,970.14
in general payments reported to CMS, 2019-2025 · $1,136 in 2025
The $1,136 reported for 2025 was more than what 88% of Family Medicine providers received nationally (typical 2025 total: $153).
Who reported paying
General payments only, top 6 by amount.
- Abbvie INC. $295.04
- Novo Nordisk INC $223.49
- Otsuka America Pharmaceutical, INC. $182.16
- Lilly USA, LLC $169.10
- Pfizer INC. $145.78
- Dexcom, INC. $127.43
Drugs and devices associated with these payments
Vraylar Rexulti Nurtec Odt Zepbound Mounjaro Wegovy Fanapt Zavzpret Rybelsus Ozempic Aimovig Cologuard Collection Kit
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Christopher Cenzer listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/9110591/christopher-cenzer